Zobrazeno 1 - 3
of 3
pro vyhledávání: '"K. V. Karabakhtsieva"'
Publikováno v:
Инновационная медицина Кубани, Vol 0, Iss 2, Pp 124-128 (2024)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme involved in the regulation of blood cholesterol levels by binding to low-density lipoprotein receptors and promoting their degradation. Pivotal studies have shown that PCSK9 inhibitio
Externí odkaz:
https://doaj.org/article/d02c6165a32646cfa69c67dc51480acb
Autor:
A. M. Namitokov, V. K, Zaphiraki, E. K. Donets, O. B. Malyarevskaya, K. V. Karabakhtsieva, A. N. Yahutl
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 6, Pp 591-596 (2023)
Currently, worldwide interest in lipoprotein(a) (LP(a) as one of the most important markers of premature and aggressive atherosclerosis is steadily growing. This trend is due to both the new data on the pathogenesis of hyperlipoproteinemia (a) and th
Externí odkaz:
https://doaj.org/article/6ca811dfb87541fe93c4d97e52484221
Autor:
V. K. Zafiraki, A. M. Namitokov, I. V. Gilevich, M. V. Gradovskaya, O. V. Malyarevskaya, K. V. Karabakhtsieva
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 3S (2023)
To date, there is no doubt about the participation of triglyceride-rich lipoproteins in atherogenesis. However, the variety of clinical manifestations of hypertriglyceridemia does not always allow timely recognition of patients with high cardiovascul
Externí odkaz:
https://doaj.org/article/95d0a8c58c0445f0a7f7c97ea608f600